PIK3CA and neoplasm: The PI3K/AKT/mTOR pathway can be activated by PIK3CA activating mutations and amplification, loss of tumor suppressors such as PTEN, INPP4B, and overexpression and/or mutation of upstream receptor tyrosine kinases (RTKs).